Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Expression dysregulation as a mediator of fitness costs in antibiotic resistance
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4646072
Author(s) Trauner, A.; Banaei-Esfahani, A.; Gygli, S. M.; Warmer, P.; Feldmann, J.; Zampieri, M.; Borrell, S.; Collins, B. C.; Beisel, C.; Aebersold, R.; Gagneux, S.
Author(s) at UniBasel Trauner, Andrej
Gygli, Sebastian
Feldmann, Julia
Borrell Farnov, Sonia
Gagneux, Sebastien
Year 2021
Title Expression dysregulation as a mediator of fitness costs in antibiotic resistance
Journal Antimicrob Agents Chemother
Volume 65
Number 9
Pages / Article-Number e0050421
Mesh terms Bacterial Proteins, genetics; DNA-Directed RNA Polymerases, genetics; Drug Resistance, Bacterial, genetics; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis, genetics; Phylogeny; Proteomics; Rifampin, pharmacology
Abstract Antimicrobial resistance (AMR) poses a threat to global health and the economy. Rifampicin-resistant Mycobacterium tuberculosis accounts for a third of the global AMR burden. Gaining the upper hand on AMR requires a deeper understanding of the physiology of resistance. AMR often results in a fitness cost in absence of drug. Identifying the molecular mechanisms underpinning this cost could help strengthen future treatment regimens. Here, we used a collection of M. tuberculosis strains providing an evolutionary and phylogenetic snapshot of rifampicin resistance, and subjected them to genome-wide transcriptomic and proteomic profiling to identify key perturbations of normal physiology. We found that the clinically most common rifampicin resistance-conferring mutation RpoB Ser450Leu imparts considerable gene expression changes, many of which are mitigated by the compensatory mutation in RpoC Leu516Pro. However, our data also provide evidence for pervasive epistasis: the same resistance mutation imposed a different fitness cost and functionally distinct changes to gene expression in genetically unrelated clinical strains. Finally, we report a likely post-transcriptional modulation of gene expression that is shared in most of the tested strains carrying RpoB Ser450Leu, resulting in an increased abundance of proteins involved in central carbon metabolism. These changes contribute to a more general trend, in which the disruption of the composition of the proteome correlates with the fitness cost of the RpoB Ser450Leu mutation in different strains.
ISSN/ISBN 1098-6596 (Electronic)0066-4804 (Linking)
URL https://doi.org/10.1128/AAC.00504-21
edoc-URL https://edoc.unibas.ch/89525/
Full Text on edoc Available
Digital Object Identifier DOI 10.1128/AAC.00504-21
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/34228548
ISI-Number WOS:000707901200016
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.353 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
05/05/2024